| Report ID | 277965 |
| Drug Identification Number | 01945270 |
| Brand name | CILOXAN |
| Common or Proper name | CILOXAN 0.3% SOLN 5ML |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CIPROFLOXACIN |
| Strength(s) | 0.3% |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC OPHTHALMIC |
| Packaging size | 1 |
| ATC code | S03AA |
| ATC description | ANTIINFECTIVES |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2026-03-23 |
| Actual discontinuation date | |
| Remaining supply date | |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Coverage is as per the mentioned timeline based on demand trend |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | [email protected] |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2026-02-12 | French | Compare |
| v3 | 2026-02-12 | English | Compare |
| v2 | 2026-02-12 | French | Compare |
| v1 | 2026-02-12 | English | Compare |
Showing 1 to 4 of 4